Tech Company Financing Transactions
Cellgate Funding Round
Cellgate, based in Redwood City, received $43 million from HealthCare Ventures, New Enterprise Associates and Sprout Group.
Transaction Overview
Company Name
Announced On
6/1/2003
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Undisclosed
Proceeds Purpose
These funds are being used to develop our portfolio of novel anti-cancer compounds, the discovery of additional leads derived from our libraries of proprietary compounds, and the evaluation of promising in-licensing opportunities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3 Twin Dolphin Dr. 100
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Overview
Cellgate is rapidly advancing a portfolio of novel anti-proliferation therapeutics that has the potential to provide patients with new treatment options. We currently have two programs progressing through clinical development as well as several oncology programs undergoing preclinical evaluation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Edward Schnipper
Chief Scientific Officer
Laurence Marton
VP - Administration
Richard Taylor
VP - R & D
Randolph Johnson
Browse more venture capital transactions:
Prev: 5/31/2003: AccentCare venture capital transaction
Next: 6/2/2003: Verari Systems venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs